Market Place
Sourcing Support
Lakeshore Bio In Definitive Deal For Going-Private Transaction
04 Nov 2025 //
PR NEWSWIRE
Lakeshore Bio Moves To Otc Market Post Nasdaq Delisting
22 Sep 2025 //
PR NEWSWIRE
LakeShore Bio Receives Nasdaq Delisting Determination Letter
12 Sep 2025 //
PR NEWSWIRE
LakeShore Biopharma Appoints Independent Advisor, Legal Counsel
10 Sep 2025 //
PR NEWSWIRE
Lakeshore Biopharma Receives Acquisition Proposal
28 Aug 2025 //
PR NEWSWIRE
LakeShore Biopharma receives preliminary acquisition proposal
18 Aug 2025 //
PR NEWSWIRE
LakeShore Biopharma Reveals 2025 Fiscal Year Financials
31 Jul 2025 //
PR NEWSWIRE
LakeShore Biopharma Secures US$15M in Private Financing
09 Jul 2025 //
PR NEWSWIRE
LakeShore Launches Novel Packaging for YSJA Rabies Vaccine
23 Apr 2025 //
PR NEWSWIRE
LakeShore Biopharma Updates on Criminal Investigation in China
12 Dec 2024 //
GLOBENEWSWIRE
LakeShore Biopharma Announces Results Of General Meeting
27 Sep 2024 //
PR NEWSWIRE
LakeShore Biopharma Announces Leadership Transitions
04 Sep 2024 //
PR NEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.